Futura Cost Of Revenue vs Depreciation And Amortization Analysis
FUM Stock | 32.95 0.22 0.66% |
Futura Medical financial indicator trend analysis is much more than just examining Futura Medical latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Futura Medical is a good investment. Please check the relationship between Futura Medical Cost Of Revenue and its Depreciation And Amortization accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Futura Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Cost Of Revenue vs Depreciation And Amortization
Cost Of Revenue vs Depreciation And Amortization Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Futura Medical Cost Of Revenue account and Depreciation And Amortization. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Futura Medical's Cost Of Revenue and Depreciation And Amortization is 0.9. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Depreciation And Amortization in the same time period over historical financial statements of Futura Medical, assuming nothing else is changed. The correlation between historical values of Futura Medical's Cost Of Revenue and Depreciation And Amortization is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Futura Medical are associated (or correlated) with its Depreciation And Amortization. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation And Amortization has no effect on the direction of Cost Of Revenue i.e., Futura Medical's Cost Of Revenue and Depreciation And Amortization go up and down completely randomly.
Correlation Coefficient | 0.9 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Cost Of Revenue
Cost of Revenue is found on Futura Medical income statement and represents the costs associated with goods and services Futura Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.Most indicators from Futura Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Futura Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Futura Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At present, Futura Medical's Issuance Of Capital Stock is projected to decrease significantly based on the last few years of reporting.
Futura Medical fundamental ratios Correlations
Click cells to compare fundamentals
Futura Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Futura Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 4.9M | 1.6M | 11.8M | 6.5M | 11.8M | 12.4M | |
Other Current Liab | 2.2M | 519.5K | 815.0K | 1.4M | 5.3M | 5.5M | |
Total Current Liabilities | 4.8M | 766.5K | 2.1M | 1.8M | 6.3M | 6.7M | |
Total Stockholder Equity | 53.7K | 853.5K | 9.7M | 4.7M | 5.5M | 4.3M | |
Property Plant And Equipment Net | 59.5K | 42.9K | 442.7K | 1.2M | 2.5M | 2.6M | |
Net Debt | (2.5M) | (1.0M) | (10.4M) | (4.0M) | (7.7M) | (7.3M) | |
Retained Earnings | (51.5M) | (53.8M) | (58.5M) | (63.7M) | (67.3M) | (64.0M) | |
Accounts Payable | 2.6M | 182.9K | 981.4K | 316.2K | 1.0M | 1.1M | |
Cash | 2.5M | 1.0M | 10.4M | 4.0M | 7.7M | 4.4M | |
Non Current Assets Total | 59.5K | 42.9K | 442.7K | 1.2M | 2.5M | 2.6M | |
Non Currrent Assets Other | 63.5K | 47.5K | 59.5K | 1.0 | 1.15 | 1.21 | |
Cash And Short Term Investments | 2.5M | 1.0M | 10.4M | 4.0M | 7.7M | 4.4M | |
Common Stock Total Equity | 241.4K | 409.2K | 409.3K | 491.3K | 564.9K | 593.2K | |
Common Stock Shares Outstanding | 204.7M | 243.7M | 271.0M | 287.5M | 301.4M | 316.5M | |
Liabilities And Stockholders Equity | 4.9M | 1.6M | 11.8M | 6.5M | 11.8M | 12.4M | |
Non Current Liabilities Total | 1.2M | 2.6M | 182.9K | 981.4K | 316.2K | 0.0 | |
Other Current Assets | 41.2K | 23.7K | 71.7K | 195.6K | 1.6M | 1.7M | |
Other Stockholder Equity | 51.2M | 52.8M | 66.4M | 67.7M | 72.2M | 75.8M | |
Total Liab | 4.8M | 766.5K | 2.1M | 1.8M | 6.3M | 6.7M | |
Property Plant And Equipment Gross | 59.5K | 42.9K | 610.6K | 1.3M | 2.8M | 2.9M | |
Total Current Assets | 4.8M | 1.6M | 11.4M | 5.3M | 9.3M | 5.2M | |
Accumulated Other Comprehensive Income | (91.0K) | (102.4K) | (123.1K) | 165.9K | 190.7K | 200.3K | |
Common Stock | 409.3K | 491.3K | 574.3K | 576.1K | 602.8K | 633.0K | |
Net Receivables | 2.3M | 534.9K | 915.9K | 1.1M | 92.5K | 87.8K | |
Property Plant Equipment | 47.5K | 59.5K | 42.9K | 442.7K | 509.1K | 534.5K | |
Net Tangible Assets | 8.9M | 53.7K | 853.5K | 9.7M | 8.8M | 5.0M | |
Short Term Investments | 8.2M | 3.5M | 372.9K | 373.9K | 336.5K | 319.7K | |
Capital Surpluse | 44.7M | 50.0M | 50.0M | 52.8M | 60.7M | 53.2M | |
Net Invested Capital | 53.7K | 853.5K | 9.7M | 4.7M | 5.5M | 4.4M | |
Net Working Capital | (5.9K) | 810.7K | 9.3M | 3.6M | 3.0M | 3.9M | |
Capital Stock | 409.3K | 491.3K | 574.3K | 576.1K | 602.8K | 561.5K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Futura Stock
Balance Sheet is a snapshot of the financial position of Futura Medical at a specified time, usually calculated after every quarter, six months, or one year. Futura Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Futura Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Futura currently owns. An asset can also be divided into two categories, current and non-current.